Treatment of acquired severe aplastic anemia: Bone marrow transplantation compared with immunosuppressive therapy-the European group for blood and marrow transplantation experience-Reference-Cited by-同舟云学术

Treatment of acquired severe aplastic anemia: Bone marrow transplantation compared with immunosuppressive therapy-the European group for blood and marrow transplantation experience

Published:2000-01 Issue:1 Volume:37 Page:69-80
ISSN:0037-1963
Container-title:Seminars in Hematology
language:en
Short-container-title:Seminars in Hematology

Author:

Bacigalupo Andrea,Brand Ronald,Oneto Rosi,Bruno Barbara,Sodé Gerard,Passweg Jakob,Locasciulli Anna,Van Lint Maria Teresa,Tichelli André,McCann Shaun,Marsh Judith,Ljungman Per,Hows Jill,Marin Pedro,Schrezenmeier Hubert

Publisher

Elsevier BV

Subject

Hematology

Reference46 articles.

1. Aplastic anemia: Evidence for an immunological mechanism;Ascensao;Lancet,1976

2. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): A report of the EBMT SAA Working Party;Bacigalupo;Br J Haematol,1988

3. Treatment of aplastic anemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: A randomized trial from the EBMT SAA working party;Bacigalupo;Br J Haematol,1993

4. Antilymphocyte globulin, cyclosporin and granulocyte stimulating factor in patients with acquired severe aplastic anemia (SAA): A pilot study of the EBMT SAA working party;Bacigalupo;Blood,1995

5. Comparison between bone marrow transplantation and antithymocyte globulin in treatment of young patients with severe aplastic anemia;Bayever;J Pediatr,1984

Cited by 210 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outpatient ATG-free hematopoietic transplantation for aplastic anemia in limited-resource environments offers excellent results: Data from a single LATAM center;Blood Cells, Molecules, and Diseases;2024-11

2. Comparison of hematopoietic stem cell transplantation and repeated intensified immunosuppressive therapy as second-line treatment for relapsed/refractory severe aplastic anemia;Frontiers in Immunology;2024-08-16

3. Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive Therapy for Newly Diagnosed Severe Aplastic Anemia;Journal of Hematology;2024-08

4. Cyclophosphamide and horse anti-thymocyte globulin versus fludarabine, reduced cyclophosphamide and rabbit anti-thymocyte globulin conditioning regimen for allogeneic hematopoietic stem cell transplantation from matched sibling donors in patients with acquired aplastic anemia;Expert Review of Hematology;2024-07-23

5. Efficacy and safety of outpatient fludarabine, cyclophosphamide, and rituximab based allogeneic hematopoietic cell transplantation in adults with severe aplastic anemia;Bone Marrow Transplantation;2024-06-15